Press Area

Press release list of thematic 'Public health'


Twin Pregnancies in France: is Vaginal Delivery Preferable After All?

Twin Pregnancies in France: is Vaginal Delivery Preferable After All?

June 02 2017

JUMODA, a prospective study sponsored by the Paris public hospitals (AP-HP) and conducted between 2014 and 2015 by teams of researchers and clinicians from Inserm, Université Paris Descartes and AP-HP, has shed new light on the mode of delivering...
Read more...


Vitamin D, a New Avenue in the Prevention of Alzheimer’s Disease?

May 19 2017

Known to be a possible cause of several chronic diseases, vitamin D deficiency is also suspected to lead to a high risk of developing Alzheimer’s disease, especially where the diet is also poor in ‘good fats’ and antioxidant carotenoids. This is w...
Read more...


Is the Link Between Early Cannabis Use and Academic Performance Becoming Clearer?

May 18 2017

The hypothesis that cannabis consumption has a direct effect on concentration, motivation, and the academic success of young people in the long-term is supported by neuroscience research data which demonstrates specific lesions in teenage users. M...
Read more...

Organic pollutants and obesity are not a good combination

Organic pollutants and obesity are not a good combination

May 09 2017

A team of researchers from Prof. Robert Barouki’s Inserm unit (Inserm Unit 1124/Université Paris Descartes), led by Prof. Xavier Coumoul, has recently shown that the Seveso dioxin, an organic pollutant found in our food and in the atmosphere, caus...
Read more...

The composition of gut microbiota can predict the efficacy and tolerance of immunotherapy in people with cancer

The composition of gut microbiota can predict the efficacy and tolerance of immunotherapy in people with cancer

April 27 2017

Teams from AP-HP, INRA, Gustave Roussy and Inserm can demonstrate the role of microbiota in the response of immunotherapy for cancer. They show that in man, the composition of gut microbiota can help to identify the patients who will respond favou...
Read more...
^ Top of page
View Edit Create here